<DOC>
	<DOCNO>NCT01760824</DOCNO>
	<brief_summary>Helicobacter pylorus ( HP ) , bacterium present many people 's stomach , one major cause ulcer cancer . Up 20 % patient infect H. pylorus may develop peptic ulcer . However , failure rate rise due multiple resistant H. pylorus infection . The eradication rate first line clarithromycin base therapy fall 80 % . Both quadruple sequential treatment regime propose first-line empirical regime . Nevertheless , comparison term efficacy side effect two regime remain unknown . The aim clinical trial compare efficacy tolerability H. pylori eradication 10-day quadruple therapy versus sequential therapy empirical first second line treatment .</brief_summary>
	<brief_title>Quadruple Versus Sequential Therapy Helicobacter Pylori Eradication</brief_title>
	<detailed_description>Helicobacter pylorus ( HP ) , bacterium present many people 's stomach , one major cause ulcer cancer . Up 20 % patient infected HP may develop peptic ulcer . However , failure rate rise due multiple resistant HP infection . The eradication rate first line clarithromycin base therapy fell 80 % increase number patient also fail second line quadruple therapy . The aim clinical trial compare efficacy tolerability H. pylori eradication 10-day quadruple therapy versus sequential therapy empirical first second line treatment . Methods : Eligible H. pylorus positive patient randomize receive either QUAD ( esomeprazole 20mg twice daily , bismuth subcitrate 120mg four time daily , tetracycline 500mg four time daily metronidazole 400mg four time daily ) 10 day SEQ ( esomeprazole 20mg twice daily 10 day , amoxicillin 1g twice daily first 5 day , clarithromycin 500mg twice daily metronidazole 400mg four time daily subsequent 5 day ) . All patient return 8 week complete treatment Urea Breath Test ( UBT ) confirm eradication . Patients fail respective therapy crossover receive alternative regimen .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Bismuth tripotassium dicitrate</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<criteria>patient age 18 , diagnose gastric HP infection Patients age less 18 , past allergy study medication , concurrent critical illness , history previous upper gastrointestinal surgery , intake nonsteroidal antiinflammatory drug , antibiotic , probiotic , bismuth preparation , proton pump inhibitor , anticoagulant steroids previous one month , pregnant breastfeed woman , drug abuser alcoholic , history previous H. Pylori treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Sequential</keyword>
	<keyword>Quadruple</keyword>
	<keyword>First</keyword>
	<keyword>Line</keyword>
	<keyword>Helicobacter</keyword>
	<keyword>pylorus</keyword>
	<keyword>infection</keyword>
</DOC>